The RHD genotype of more than 96% of D- Japanese could be determined by conventional PCR-SSP. In addition, we identified a novel DEL allele having c.1252T>A mutation and a novel RHD silencing allele having c.761C>G nonsense mutation.
We identified three known and ten new silent KEL alleles from Japanese individuals with the K phenotype. The KEL allele with the c.299G>C (p.Cys100Ser) mutation was the most frequent.
Aim: The present study reports a single nucleotide polymorphism (SNP) of ATP-binding cassette, membrane G2 (ABCG2) gene may influence the expression of Jra antigen on red blood cells (RBCs).
Methods: Genomic DNAs from 474 random donors were examined for SNPs, c.-262C/T, c.376C/T, and c.421C/A by polymerase chain reaction. The amount of Jra antigen of RBCs was assayed by flow cytometry using human monoclonal anti-Jra (HIRO-133). We classified them in three groups: Group I (wild type) with no variance of three loci (c.-262C, c.376C, and c.421C), Group II with SNP of c.376T and/or c.421A but with c.-262C, and Group III with SNP loci c.-262T.
Results: Compared to Group I (n = 185), Group II (n = 263) showed decreased Jra expression on RBCs by 20–75%, whereas SNP c.-262T (Group III) increased Jra expression with more than 50%. The predicted open structure of 5′ untranslated region formed by c.-262T may recruit the initiation complex for translation or increase the rate of ribosomal scanning, thereby enhancing the frequency of protein synthesis.
Conclusion: Among a healthy Japanese population, the SNPs c.376C>T and/or c.421C>A downregulated expression of Jra, whereas SNP c.-262C>T augmented Jra expression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.